Invention Grant
- Patent Title: CD27 single chain molecules and encoding nucleic acids
-
Application No.: US15172393Application Date: 2016-06-03
-
Publication No.: US09725495B2Publication Date: 2017-08-08
- Inventor: Oliver Hill , Christian Gieffers , Meinolf Thiemann
- Applicant: APOGENIX AG
- Applicant Address: DE Heidelberg
- Assignee: Apogenix AG
- Current Assignee: Apogenix AG
- Current Assignee Address: DE Heidelberg
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Priority: EP08013112 20080721
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C12N15/62 ; C12N15/79 ; C07K14/525 ; C07K16/00 ; A61K38/00
Abstract:
The present invention refers to single-chain fusion proteins comprising three soluble TNF superfamily (TNFSF) cytokine domains and nucleic acid molecules encoding these fusion proteins. The fusion proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.
Public/Granted literature
- US20160272695A1 CD27 SINGLE CHAIN MOLECULES Public/Granted day:2016-09-22
Information query
